CGM Usage and Health Outcomes among People with T1D and COVID-19
Background and Aims: Continuous glucose monitoring (CGM) improves glycemic control and reduces complications in patients with type 1 diabetes (T1D). This…
Real-time Continuous Glucose Monitoring (CGM) Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes (T1D)
Background and Aims: The management of type 1 diabetes (T1D) involves strict glucose control to avoid acute complications. The use of…
Factors Associated with Optimal Glycemic Management in Adults with Type 1 Diabetes: Results from the T1D Exchange Quality Improvement Collaborative (QIC)
Background: The management of type 1 diabetes (T1D includes aiming to achieve optimal glucose management to avoid complications, but this…
“Six Habits”: Quality Metrics to Support Glycemic Outcomes in Type 1 Diabetes
Objective: To evaluate the relationship of six diabetes self-management habits with Hemoglobin A1c (HbA1c) and by race and insurance. Methods:…
HbA1c trends in the T1D Exchange Quality Improvement Collaborative (QIC) 2017-2020
Background: The T1DX-QI was launched in 2016 with 10 participating centers and now has over 30 U.S. endocrinology centers that…
Insulin Pump Use and Glycemic Control Among Patients with Type 1 Diabetes: Trends from the Largest U.S. Based Multi-Center Observational Study
Background: The use of continuous subcutaneous insulin infusion (CSII), or insulin pump therapy, has been shown to improve glycemic control…
T1D Exchange Registry: Current Insights on Participant Outcomes
The T1D Exchange Registry was launched June of 2019 to increase participation in research and probe a diverse set of…
Insulin Pump Use in Patients with Type 1 Diabetes: Real World Data from a Large U.S. Based Multi-Center Observational Study
Background: Insulin pump use is known to improve glycemic control in patients with type 1 diabetes (T1D), however, uptake of…
CGM Use and A1c: A transatlantic comparison of the DPV Initiative and T1D Exchange Quality Improvement Collaborative (QIC)
The utility of CGM to improve glycemic control and QoL is well established; however, real-world use of CGM varies among…
T1D Exchange Registry: Current Insights on Participant Outcomes
The T1D Exchange Registry was launched June of 2019 to increase participation in research and probe a diverse set of…
